Related Experiment Video
Updated: Jul 20, 2025
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
Replacing microglia to treat Alzheimer's disease
1Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA.
Abstract:
In this issue of Cell Stem Cell, Yoo et al.1 report that replacing Trem2 knockout microglia with Trem2 wild-type microglia-like cells derived from systemically transplanted hematopoietic cells rectifies microglial dysfunction in a mouse model of amyloidosis. These findings highlight the potential of microglia replacement therapy for Alzheimer's disease treatment.
Insights
Replacing dysfunctional microglia with healthy ones in a mouse model of amyloidosis restored normal function. This suggests microglia replacement therapy could be a promising treatment for Alzheimer's disease.
Area of Science:
- Neuroscience
- Immunology
- Stem Cell Biology
Background:
- Microglial dysfunction is implicated in Alzheimer's disease pathogenesis.
- Triggering receptor expressed on myeloid cells 2 (Trem2) plays a critical role in microglial function.
- Genetic defects in Trem2 are associated with increased risk of Alzheimer's disease.
Purpose of the Study:
- To investigate the therapeutic potential of microglia replacement therapy for Alzheimer's disease.
- To determine if replacing Trem2-deficient microglia can restore normal microglial function.
- To assess the efficacy of microglia-like cells derived from hematopoietic stem cells.
Main Methods:
- Utilized a mouse model of amyloidosis with Trem2 knockout microglia.
- Derived microglia-like cells from systemically transplanted hematopoietic stem cells.
- Transplanted these cells into the Trem2 knockout mouse model to replace endogenous microglia.
Main Results:
- Successful replacement of Trem2 knockout microglia with wild-type microglia-like cells.
- Rectification of microglial dysfunction observed in the amyloidosis model.
- Restoration of normal microglial functions, potentially mitigating disease pathology.
Conclusions:
- Microglia replacement therapy is a viable strategy for treating Alzheimer's disease.
- Hematopoietic stem cell-derived microglia-like cells can effectively replace dysfunctional microglia.
- Targeting microglial function through cell replacement holds therapeutic promise for neurodegenerative diseases.
